AMD Fluid Resolution: Optimizing Real-world Outcomes in nAMD Treatment
Chairperson(s): F.G. Holz GERMANY
Speakers:
Presentations:
Speakers and presentations:
F.G. Holz GERMANY
18:15 Welcome, ARS and review of EURETINA AMD clinical trends survey data
S. Wolf SWITZERLAND
18:20 Best practices for diagnosing & monitoring AMD
N. Eter GERMANY
18:30 nAMD patient selection and outcome goals for Anti-VEGF treatment
R. Tadayoni FRANCE
18:40 nAMD treatment protocols and therapy decisions
R. Singh USA
18:50 Real-world experience with new Anti-VEGFs
F.G. Holz GERMANY
19:00 Final ARS & panel discussion
19:15 End of Session